메뉴 건너뛰기




Volumn 154, Issue 5, 2006, Pages 988-991

Regression of extranodal natural killer/T-cell lymphoma, nasal type with denileukin diftitox (Ontak®) and bexarotene (Targretin®): Report of a case

Author keywords

Bexarotene; Cutaneous T cell lymphoma; Denileukin diftitox; Natural killer lymphoma

Indexed keywords

BEXAROTENE; DENILEUKIN DIFTITOX; DOXORUBICIN;

EID: 33645816150     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07151.x     Document Type: Article
Times cited : (7)

References (16)
  • 1
    • 20844443468 scopus 로고    scopus 로고
    • WHO-EORTC classification for cutaneous lymphomas
    • Willemze R Jaffe ES Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 3768 85.
    • (2005) Blood , vol.105 , pp. 3768-85
    • Willemze, R.1    Jaffe, E.S.2    Burg, G.3
  • 2
    • 2542451247 scopus 로고    scopus 로고
    • Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: A morphologic, immunophenotypic, and molecular study of 50 patients
    • Massone C Chott A Metze D et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004 28 719 35.
    • (2004) Am J Surg Pathol , vol.28 , pp. 719-35
    • Massone, C.1    Chott, A.2    Metze, D.3
  • 4
    • 0037302031 scopus 로고    scopus 로고
    • Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop
    • Santucci M Pimpinelli N Massi D et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003 97 610 27.
    • (2003) Cancer , vol.97 , pp. 610-27
    • Santucci, M.1    Pimpinelli, N.2    Massi, D.3
  • 5
    • 0027485223 scopus 로고
    • Epithelioid granulomas in small noncleaved cell lymphoma
    • Chan JK Tsang WY. Epithelioid granulomas in small noncleaved cell lymphoma. Am J Surg Pathol 1993 17 1068.
    • (1993) Am J Surg Pathol , vol.17 , pp. 1068
    • Chan, J.K.1    Tsang, W.Y.2
  • 6
    • 0023928446 scopus 로고
    • T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections
    • Jones JF Shurin S Abramowsky C et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988 318 733 41.
    • (1988) N Engl J Med , vol.318 , pp. 733-41
    • Jones, J.F.1    Shurin, S.2    Abramowsky, C.3
  • 7
    • 1842787089 scopus 로고    scopus 로고
    • CD56+ lymphoma with skin involvement: Clinicopathologic features and classification
    • Gniadecki R Rossen K Ralfkier E et al. CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Arch Dermatol 2004 140 427 36.
    • (2004) Arch Dermatol , vol.140 , pp. 427-36
    • Gniadecki, R.1    Rossen, K.2    Ralfkier, E.3
  • 8
    • 0030974251 scopus 로고    scopus 로고
    • Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
    • Chan JK Sin VC Wong KF et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997 89 4501 13.
    • (1997) Blood , vol.89 , pp. 4501-13
    • Chan, J.K.1    Sin, V.C.2    Wong, K.F.3
  • 9
    • 0032939150 scopus 로고    scopus 로고
    • Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
    • Natkunam Y Smoller BR Zehnder JL et al. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol 1999 23 571 81.
    • (1999) Am J Surg Pathol , vol.23 , pp. 571-81
    • Natkunam, Y.1    Smoller, B.R.2    Zehnder, J.L.3
  • 10
    • 0031962152 scopus 로고    scopus 로고
    • Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
    • Cheung MM Chan JK Lau WH et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998 16 70 7.
    • (1998) J Clin Oncol , vol.16 , pp. 70-7
    • Cheung, M.M.1    Chan, J.K.2    Lau, W.H.3
  • 11
    • 4143108007 scopus 로고    scopus 로고
    • CD56+ hematological neoplasms presenting in the skin: A retrospective analysis of 23 new cases and 130 cases from the literature
    • Bekkenk MW Jansen PM Meijer CJ et al. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004 15 1097 108.
    • (2004) Ann Oncol , vol.15 , pp. 1097-108
    • Bekkenk, M.W.1    Jansen, P.M.2    Meijer, C.J.3
  • 12
    • 0035871570 scopus 로고    scopus 로고
    • Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
    • Mraz-Gernhard S Natkunam Y Hoppe RT et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001 19 2179 88.
    • (2001) J Clin Oncol , vol.19 , pp. 2179-88
    • Mraz-Gernhard, S.1    Natkunam, Y.2    Hoppe, R.T.3
  • 13
    • 0028361965 scopus 로고
    • Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms
    • Nakase K Kita K Nasu K et al. Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms. Am J Hematol 1994 46 179 83.
    • (1994) Am J Hematol , vol.46 , pp. 179-83
    • Nakase, K.1    Kita, K.2    Nasu, K.3
  • 14
    • 0035863468 scopus 로고    scopus 로고
    • Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
    • Olsen E Duvic M Frankel A et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 2001 19 376 88.
    • (2001) J Clin Oncol , vol.19 , pp. 376-88
    • Olsen, E.1    Duvic, M.2    Frankel, A.3
  • 15
    • 0037103316 scopus 로고    scopus 로고
    • Immunomodulatory effects of RXR rexinoids: Modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox
    • Gorgun G Foss F. Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox. Blood 2002 100 1399 403.
    • (2002) Blood , vol.100 , pp. 1399-403
    • Gorgun, G.1    Foss, F.2
  • 16
    • 2542472359 scopus 로고    scopus 로고
    • Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression
    • Morgan SJ Seymour JF Prince HM et al. Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression. Clin Cancer Res 2004 10 3572 5.
    • (2004) Clin Cancer Res , vol.10 , pp. 3572-5
    • Morgan, S.J.1    Seymour, J.F.2    Prince, H.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.